SMMT   $23.14  -5.72% Market Closed After Close 23.25 0.48%

Summit Therapeutics Inc
Total Cash 325.47M
totalCashPerShare 0.449
EBITDA -143.59M
Total Debt 108.70M
quickRatio 2.329
currentRatio 2.346
Total Revenue
debtToEquity 55.725
Revenue/Share
ROA -0.31011
ROE -1.0276899
grossProfits
freeCashflow -28.68M
operatingCashflow -97.49M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 22.92B
forwardPE -106.43333
floatShares 101.36M
sharesOutstanding 734.89M
sharesShort 18.23M
sharesShortPriorMonth 17.79M
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.88%
heldPercentInstitutions 0.11%
Short Ratio help_outline 10.58%
shortPercentOfFloat 0.17%
impliedSharesOutstanding
bookValue 0.269
Price To Book help_outline 118.70
earningsQuarterlyGrowth
netIncomeToCommon -161.69M
trailingEps -0.11%
forwardEps -0.30%
enterpriseToEbitda -159.60
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.07 3Q 2024
institutionsCount 168
lastUpdated Sept. 16, 2024, 12:46 p.m.